J Allergy Clin Immunol. 2026 Apr 2:S0091-6749(26)00222-8. doi: 10.1016/j.jaci.2026.03.017. Online ahead of print.
ABSTRACT
BACKGROUND: Asthma has heterogeneous risk factors, subtypes, and treatments. It is often unclear how to stratify this heterogeneity in scientific studies and clinical care. Genetics could explain root causes of this clinical heterogeneity, called endotypes, but prior studies have used models that are not designed for complex diseases like asthma.
OBJECTIVE: We aimed to find genetic effects that partly explain different asthma endotypes.
METHODS: We used recent powerful and robust statistical models of context-specific genetic effects in complex traits. We identified genetic subtypes by clustering clinical asthma features in a case/control cohort, GALA II. We replicated the genetic endotypes in UK Biobank with gene-context interaction tests.
RESULTS: Asthma-associated SNPs, polygenic scores, and genome-wide heritability revealed subtype-specific genetic endotypes correlated with type 2 inflammation (T2), allergy, and neuroticism. We validated the T2 associations with molecular data including nasal RNA-seq. In UK Biobank, we replicated these endotypes and found they interact with several polygenic scores and drug-relevant genes.
CONCLUSION: Our results show how context-specific genetic effects can unravel biomedically meaningful endotypes of complex disease and suggest novel precision treatment strategies.
PMID:41935671 | DOI:10.1016/j.jaci.2026.03.017
